CBN + cannaflavin A

Cannaflavin-A has been discovered to inhibit the inflammatory molecule PGE-2 and reduce inflammation 30 times better than Aspirin. Research is underway to distinguish cannaflavins from more common flavonoids. For example, it was recently discovered that cannabis flavonoid “cannaflavin-A” inhibits “PGE-2,” a prostaglandin responsible for inflammation known for responding well to nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin. The study showed that cannaflavin-A reduces inflammation and is exponentially more powerful than aspirin.